EVOK
Evoke Pharma, Inc.
1.25
USD
This page is just a preview of the data found in TrendSpider’s full version
Evoke Pharma, Inc. stock is up 7.76% since 30 days ago. The next earnings date is Mar 19, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 18.18% of the previous 10 December’s closed higher than November.
Evoke Pharma, Inc. is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabetic gastroparesis in females. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers.
